Child deaths from flu + MRSA: CDC confirmation

By Maryn / September 9, 2009

Hello again, constant readers. It’s been an exciting few weeks at Casa Superbug. I’ll spare you the details — most of them are both grueling and trivial — but out of the murk, here is a piece of excellent news: SUPERBUG has been edited, revised and sent back to the publisher, who has sent it […]

Read More

Non-medical use of antibiotics: A whole new problem with ethanol

By Maryn / August 20, 2009

Constant readers, we’ve talked frequently about the emerging recognition that the enormous use of antibiotics in agriculture is fueling the development of resistance, both directly in the case of specific organisms such as MRSA ST-398, and indirectly in that it pushes the evolution of resistance factors that bacteria then trade amongst themselves. (For a superb […]

Read More

Another death from H1N1 flu + MRSA

By Maryn / August 19, 2009

Thanks to a commenter who alerted me to this sad story: A teenager in Austin died of a combination of H1N1 flu and MRSA pneumonia. Constant readers will know that we have been watching for this for a while; MRSA pneumonia is a known and dangerous complication of any flu infection. For stories for CIDRAP […]

Read More

One more set of recommendations

By Maryn / August 13, 2009

… and then next week I’ll be back to analyzing the medical literature: A stack of interesting new journal articles is threatening to topple and bury my computer. For the moment, though: First, the Hearst newspapers chain has conducted a nationwide investigation into medical errors that should be required reading for anyone who wonders why […]

Read More

Catching up on some reading: health care reform, food bugs, vaccine, MRSA+flu

By Maryn / August 7, 2009

Folks, while I was caught in travel hell, some excellent stories and blogposts were released. Here’s a quick round-up of recommendations for a rainy weekend: At Roll Call (covers Congress like a blanket), Ramanan Laxminarayan, PhD MPH, of the rational-use-of-antibiotics project Extending the Cure and infection-control physician Ed Septimus, MD make a strong argument for […]

Read More

Federal plan to reduce HAIs: public meetings

By Maryn / July 24, 2009

Let’s switch back for a moment to MRSA and other infections in hospitals. An estimated 1.7 million healthcare-associated infections (HAIs) occur in the US each year. Approximately 99,000 of the infected die. Care for the infected costs the health care system $33 billion (yes, with a B) each year. The US Department of Health and […]

Read More

Decolonization: disappointing news

By Maryn / July 23, 2009

I know that many of you who are MRSA patients, especially with recurrent infections, are especially interested in the issue of decolonization, the grueling regimen of antibiotic nasal gel (containing mupirocin; usually sold as Bactroban) combined with body washes with chlorhexidine (Hibiclens) that is believed to eradicate MRSA carriage in the nose and on the […]

Read More

Media round-up: recommending MRSA stories

By Maryn / July 22, 2009

By chance — or is it because interest is really picking up? — a couple of worthwhile stories on MRSA have been published almost simultaneously: For when the science gets wonky: Environmental Health Perspectives has an excellent lay-language explanation of how drug resistance emerges and spreads — with gorgeous graphics! For when yet another drug […]

Read More

New England Journal editorial: MRSA, H1N1 parallels

By Maryn / July 22, 2009

There’s a very interesting piece in a recent New England Journal of Medicine (unfortunately, only the abstract is online) that draws parallels between MRSA and public expectations for pandemic flu. Written by Dr. Kent Sepkowitz, chief of infection control at Memorial Sloan-Kettering Cancer Center in New York and one of the authors of the “Medical […]

Read More

Antibiotic overuse in animals: Obama administration comes out against

By Maryn / July 13, 2009

For anyone who cares about the overuse of antibiotics in food animals, and the resistant bacteria that overuse has been shown to produce, this is important news. In testimony today, new FDA Commissioner Dr. Joshua Sharfstein announced the administration’s opposition to the use of growth promoters: sub-therapeutic doses of antibiotics used not as disease treatment, […]

Read More